Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
Rosa Maria Vitale, Fabio Arturo Iannotti, Pietro Amodeo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4876-4876
Open Access | Times Cited: 62

Showing 26-50 of 62 citing articles:

Effects of cannabinoids on ligand-gated ion channels
Murat Öz, Keun‐Hang Susan Yang, Mohamed Mahgoub
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 8
Cannabidiol as a modulator of α7 nicotinic receptors
Juan Facundo Chrestia, María del Carmen Esandi, Cecilia Bouzat
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 8
New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect
Matti Bock Guldager, Caroline Biojone, Nicole Rodrigues da Silva, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111029-111029
Open Access | Times Cited: 1
GABRG2 mutations in genetic epilepsy with febrile seizures plus: structure, roles, and molecular genetics
Xinxiao Li, Shengnan Guo, Yangyang Sun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
João Luís Q. Simei, José Diogo R. Souza, João Francisco Cordeiro Pedrazzi, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1644-1644
Open Access | Times Cited: 1
Identification and Characterization of Cannabidiol as an OX1R Antagonist by Computational and In Vitro Functional Validation
Rosa Maria Vitale, Fabio Arturo Iannotti, Aniello Schiano Moriello, et al.
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1134-1134
Open Access | Times Cited: 11
Judicialização de produtos à base de canabidiol no Brasil: uma análise de 2019 a 2022
Ronaldo Portela, Daniel Marques Mota, Paulo José Gonçalves Ferreira, et al.
Cadernos de Saúde Pública (2023) Vol. 39, Iss. 8
Open Access | Times Cited: 4
Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB2 receptor
Jara Bouma, Jeremy D. Broekhuis, Cas van der Horst, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115924-115924
Open Access | Times Cited: 4
Pharmacological and morphological features and socioeconomic aspects of cannabidiol: A literature review
Oles-Pylyp Hasiuk
International Journal of Medicine and Medical Research (2023), pp. 47-59
Open Access | Times Cited: 4
Phytocannabinoids in neuromodulation: From omics to epigenetics
Subhadip Banerjee, Debolina Saha, Rohit Sharma, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118201-118201
Closed Access | Times Cited: 1
Behavioral effects of two cannabidiol and cannabigerol-rich formulas on mice
Marinella Carone, Marika Premoli, Sara Anna Bonini, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39938-e39938
Open Access | Times Cited: 1
In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugs
Cuiying Xiao, Oksana Gavrilova, Naili Liu, et al.
Purinergic Signalling (2023) Vol. 19, Iss. 3, pp. 551-564
Open Access | Times Cited: 3
Assessing the bioactivity of cannabis extracts in larval zebrafish
Jessica Nixon, Hanan Abramovici, Ashley Cabecinha, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 8
The Effects of Cannabidiol on Aqueous Humor Outflow and Trabecular Meshwork Cell Signaling
Alyssa S. Aebersold, Zhao-Hui Song
Cells (2022) Vol. 11, Iss. 19, pp. 3006-3006
Open Access | Times Cited: 5
Strain, Sex, and Time Dependent Antidepressant-like Effects of Cannabidiol
Gabriela Pandini Silote, Michelle Carvalho Gatto, Amanda Eskelund, et al.
(2021)
Open Access | Times Cited: 5
Cannabidiol prevents methamphetamine-induced neurotoxicity by modulating dopamine receptor D1-mediated calcium-dependent phosphorylation of methyl-CpG-binding protein 2
Baoyu Shen, Ruilin Zhang, Genmeng Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
CBD treatment following early life seizures alters orbitofrontal-striatal signaling during adulthood
Natalie A Cashen, Michelle L. Kloc, Davi Pressman, et al.
Epilepsy & Behavior (2024) Vol. 152, pp. 109638-109638
Closed Access
Diagnosis and Treatment of Cannabis-Related Disorders
David A. Gorelick
Elsevier eBooks (2024)
Closed Access
Parallel Algorithm for Discovering and Comparing Three-Dimensional Proteins Patterns
Alejandro Valdés-Jiménez, Miguel Reyes‐Parada, Gabriel Núñez, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics (2024) Vol. 21, Iss. 3, pp. 508-515
Open Access
Eukaryotic Initiation Translation Factor 2A activation by cannabidiolic acid alters the protein homeostasis balance in glioblastoma cells
Maria Laura Bellone, Azmal Ali Syed, Rosa Maria Vitale, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132968-132968
Open Access
Therapeutic potential of cannabidiol in depression
Matti Bock Guldager, Adriano Maia Chaves Filho, Caroline Biojone, et al.
International review of neurobiology (2024), pp. 251-293
Closed Access
Historical perspective on the therapeutic potential of cannabidiol
Francisco Silveira Guimarães
International review of neurobiology (2024), pp. 1-9
Closed Access
Cannabis in anticancer drug development
Ernest Matambo, Andrew G. Mtewa, Tadala Mzengo, et al.
Elsevier eBooks (2024), pp. 489-507
Closed Access
Preliminary evaluation of the neuroprotective activity of Cannabidiol in combination with some current medicinal drugs <i>in vitro</i>
Jesús Vélez-Huerta, Eder Arredondo‐Espinoza, Karla Ramírez‐Estrada, et al.
DELETED (2024) Vol. 25, Iss. 4
Open Access
Cannabidiol Modulates Neuroinflammatory Markers in a PTSD Model Conducted on Female Rats
Anna Portugalov, Gaia Peled, S Zorin, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1384-1384
Open Access

Scroll to top